Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Sonpiretigene isteparvovec by Nanoscope Therapeutics for Juvenile Macular Degeneration (Stargardt Disease): Likelihood of Approval
Sonpiretigene isteparvovec is under clinical development by Nanoscope Therapeutics and currently in Phase II for Juvenile Macular Degeneration (Stargardt Disease)....
Data Insights
Sonpiretigene isteparvovec by Nanoscope Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Sonpiretigene isteparvovec is under clinical development by Nanoscope Therapeutics and currently in Phase III for Retinitis Pigmentosa (Retinitis). According to...